Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
Product: Glivec
Active Ingredient: Imatinib mesilate 119.5mg equivalent to imatinib base 100mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Novartis New Zealand Limited Pharmaceutical Sector
Manufacturer: Novartis Pharma Stein AG, Switzerland
Note: This consent is valid for two years from 14 April 2007.
Product: Glivec
Active Ingredient: Imatinib mesilate 478mg equivalent to imatinib base 400mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Novartis New Zealand Limited Pharmaceutical Sector
Manufacturer: Novartis Pharma Stein AG, Switzerland
Note: This consent is valid for two years from 14 April 2007.
Dated this 29th day of March 2007.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).